Cynthia Mattia‐Goldberg

A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata

Kristof Chwalisż, Lois Larsen, Cynthia Mattia‐Goldberg et al. · Fertility and Sterility · 2007 · 138 citations · Full text

Uterine Leiomyomata, Hormonal Contraceptive, Uterine Fibroids +11

Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution

Robert J. Przybelski, Elaine K. Daily, James C. Kisicki et al. · Critical Care Medicine · 1996 · 137 citations

Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty

Peter A. Lee, Karen O. Klein, Nelly Mauras et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 68 citations · Full text

The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women

Kristof Chwalisż, W. Elger, Therese Stickler et al. · Human Reproduction · 2005 · 61 citations · Full text

Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery

E. Kirk Neely, PeterA Lee, CliffordA Bloch et al. · International Journal of Pediatric Endocrinology · 2010 · 59 citations · Full text

Tanner Breast Stage, Fertility, Human Growth +20